| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 36,407 | 46,176 | 10,006 | 7,642 | | Cost of Revenue | 3,206 | 5,884 | 4,725 | 1,968 | | | Gross Profit | 33,201 | 40,292 | 5,281 | 5,674 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 14,533 | 12,561 | 12,241 | 14,891 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 18,668 | 27,731 | (6,960) | (9,217) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 501 | 574 | (447) | (229) | | Earnings Before Interest And Taxes | 19,169 | 28,305 | (7,407) | (9,446) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 19,169 | 28,305 | (7,407) | (9,446) | | Income Tax Expense | 6,664 | 9,126 | (2,153) | (2,984) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,505 | 19,179 | (5,254) | (6,462) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,505 | 19,179 | (5,254) | (6,462) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,505 | $19,179 | ($5,254) | ($6,462) |
|
0.51% Nasdaq 
Income Statement
